High Survivin and Low Zinc Finger of the Cerebellum 1 Expression Indicates Poor Prognosis in Triple-negative Breast Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High Survivin and Low Zinc Finger of the Cerebellum 1 Expression Indicates Poor Prognosis in Triple-negative Breast Carcinoma

Published:2019 Issue:2 Volume:22 Page:248
ISSN:1738-6756
Container-title:Journal of Breast Cancer
language:en
Short-container-title:J Breast Cancer

Author:

Shi Chun-Tao¹^ORCID,Ma Jun²^ORCID,Shi Qi-Feng³^ORCID,Zhang Ye³^ORCID,Wang Hao-Nan⁴^ORCID

Affiliation:

1. Department of General Surgery, Wuxi Xishan People's Hospital, Wuxi, China.

2. Department of Urology, Kunshan Hospital of Traditional Chinese Medicine, Kunshan, China.

3. Department of Pathology, Wuxi Xishan People's Hospital, Wuxi, China.

4. Department of Oncology, Wuxi Fifth People's Hospital, Wuxi, China.

Funder

Wuxi Youth Projection of Health and family planning commission

Publisher

Korean Breast Cancer Society

Subject

Cancer Research,Oncology

Link

https://synapse.koreamed.org/pdf/10.4048/jbc.2019.22.e20

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survivin expression as a prognostic marker for breast cancer;Revista da Associação Médica Brasileira;2023

2. Regulation of survivin and caspase/Bcl-2/Cyto-C signaling by TDB-6 induces apoptosis of colorectal carcinoma LoVo cells;Journal of Gastrointestinal Oncology;2022-10

3. Significance of combined TGF‑β1 and survivin expression on the prognosis of patients with triple‑negative breast cancer;Oncology Letters;2022-04-29

4. Paeonol induces antitumor effects in hepatocellular carcinoma cells through survivin via the cyclooxygenase-2/prostaglandin E2 signaling pathway;Translational Cancer Research;2020-11

5. Down-regulated microRNA-223 or elevated ZIC1 inhibits the development of pancreatic cancer via inhibiting PI3K/Akt/mTOR signaling pathway activation;Cell Cycle;2020-10-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3